KRYS

Krystal Biotech, Inc.

SEC CIK 1711279
$348.06 +28.6% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
39
Most recent
Advertisement

At a glance

Insiders at KRYS have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Janney Daniel sold $7.05M of KRYS, trimming their stake 27%.

Most active filer: Janney Daniel, with 38 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for KRYS, newest first
View on SEC EDGAR ↗
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed Jun 9, 2023 ΔOwn −3.8%

Janney Daniel sold $639.3K of KRYS, trimming their stake 4%.

−$639.3K
5,000 sh @ $128
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed May 23, 2023 ΔOwn −24%

Janney Daniel sold $4.75M of KRYS, trimming their stake 24%.

−$4.75M
50,000 sh @ $95
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed May 11, 2023 ΔOwn −7.6%

Janney Daniel sold $1.55M of KRYS, trimming their stake 8%.

−$1.55M
17,100 sh @ $91
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed Apr 21, 2023 ΔOwn −3.4%

Janney Daniel sold $713.5K of KRYS, trimming their stake 3%.

−$713.5K
7,900 sh @ $90
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed Dec 14, 2021 ΔOwn −27%

Janney Daniel sold $7.05M of KRYS, trimming their stake 27%.

−$7.05M
100,000 sh @ $71
Advertisement
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed Sep 3, 2019 ΔOwn −8.1%

Janney Daniel sold $1.49M of KRYS, trimming their stake 8%.

−$1.49M
32,190 sh @ $46
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed Sep 3, 2019 ΔOwn −12%

Janney Daniel sold $2.6M of KRYS, trimming their stake 12%.

−$2.6M
55,794 sh @ $47
KRYS
Sell JANNEY DANIEL · Director · Open-market sale · filed Sep 3, 2019 ΔOwn −0.2%

Janney Daniel sold $33.3K of KRYS.

−$33.3K
700 sh @ $48
KRYS
Buy Riley Antony A · Chief Financial Officer · Open-market purchase · filed May 24, 2018 ΔOwn NEW

Riley Antony A, KRYS's CFO, spent $30.1K of their own money on 2,800 shares at $11, opening a brand-new position.

+$30.1K
2,800 sh @ $11
Advertisement

About KRYS insider activity

This page tracks every recent Form 4 filed for Krystal Biotech, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is KRYS insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Krystal Biotech, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.